#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute myeloid leukaemia Fibrous dysplasia of bone Pneumonia Infertility male Asthma Albright's disease B precursor type acute leukaemia Urethral valves Thrombocytopenia Marginal zone lymphoma Medulloblastoma recurrent Craniocerebral injury Burkitt's lymphoma Non-small cell lung cancer recurrent Infective uveitis More trials…

    Learn about Rare Diseases

    Angiosarcoma metastatic – Diagnostics Kearns-Sayre syndrome – Trials in Disease Turner’s syndrome – Basic Information Primary mediastinal large B-cell lymphoma – Treatment Amyotrophic lateral sclerosis – Treatment Metachromatic leukodystrophy Chordoma – Basic Information Pleomorphic leiomyosarcoma Turner’s syndrome Synovial sarcoma metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ribonucleic Acid K10 AZD0292 Haloperidol Palonosetron Clodronate Disodium ZODASIRAN Alectinib Hydrochloride RO7837195 Doxribtimine Oxygen Ph.eur. Obeticholic Acid Landiolol Hydrochloride Rbl015.2 Potato Starch Ranolazine Ads-010 Utreloxastat Suxamethonium Chloride Repotrectinib Ecoo18A More therapies…

    Learn about Your Condition

    Venous thrombosis Endometrial cancer stage II Dent's disease Paraganglion neoplasm Osteosarcoma Respiratory distress Pigmentary glaucoma Lymphocytic leukaemia Acute HIV infection Von Willebrand's disease Rubella Labour induction Glioblastoma Exposure via breast milk COVID-19 More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Palbociclib
    • Leuprorelin Acetate
    Austria Belgium France Germany Italy The Netherlands +3

  • Study of Rituximab versus Placebo to Improve Lung Function in Patients with Granulomatous Lymphocytic Interstitial Lung Disease (GLILD)

    Recruiting

    2 1 1
    Investigated Diseases:
    • Interstitial lung disease
    Investigated Drugs:
    • Sodium Chloride
    • Rituximab
    Denmark Finland Norway Sweden

  • Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • (1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
    Bulgaria Czechia Germany Poland

  • Study on Frozen Shoulder: Evaluating the Effectiveness of Physiotherapy, Triamcinolone Acetonide, and Lidocaine in Improving Shoulder Function and Reducing Pain

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Periarthritis
    Investigated Drugs:
    • Cetrimide
    • Lidocaine
    • Triamcinolone Acetonide
    Norway

  • Study on Digital Monitoring of Symptoms in Patients with Advanced Kidney Cancer Treated with Cabozantinib and Nivolumab

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nivolumab
    • Cabozantinib
    France

  • Study on Amiodarone Hydrochloride for Treating Atrial Fibrillation in Critically Ill Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Amiodarone Hydrochloride
    Denmark
Previous Page
1 … 200 201 202 203 204 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!